Patricia Ho

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 20

Top Topics

Radiation Induced

Top Venues

Nature communications

Nature biotechnology

This page only lists publications with an associated author ORCID identifier.

Publications

Karan Luthria, Parin Shah, Blake Caldwell, Johannes C Melms, Sinan Abuzaid, Viktoria Jakubikova, D Zack Brodtman, Sminu Bose, Amit Dipak Amin, Patricia Ho, Jana Biermann, Somnath Tagore, Matthew A Ingham, Gary K Schwartz, Benjamin Izar
Single-cell profiling of sarcomas from archival tissue reveals programs associated with resistance to immune checkpoint blockade. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Zachary H Walsh, Parin Shah, Neeharika Kothapalli, Shivem B Shah, Gergő Nikolényi, D Zack Brodtman, Giuseppe Leuzzi, Meri Rogava, Michael Mu, Patricia Ho, Sinan Abuzaid, Neil Vasan, Mohammed AlQuraishi, Joshua D Milner, Alberto Ciccia, Johannes C Melms, Benjamin Izar
Mapping variant effects on anti-tumor hallmarks of primary human T cells with base-editing screens. Nature biotechnology (2024)
Nasser K Altorki, Zachary H Walsh, Johannes C Melms, Jeffery L Port, Benjamin E Lee, Abu Nasar, Cathy Spinelli, Lindsay Caprio, Meri Rogava, Patricia Ho, Paul J Christos, Ashish Saxena, Olivier Elemento, Bhavneet Bhinder, Casey Ager, Amit Dipak Amin, Nicholas J Sanfilippo, Vivek Mittal, Alain C Borczuk, Sylvia C Formenti, Benjamin Izar, Timothy E McGraw
Author Correction: Neoadjuvant durvalumab plus radiation versus durvalumab alone in stages I-III non-small cell lung cancer: survival outcomes and molecular correlates of a randomized phase II trial. Nature communications 15 (1) (2024)
Nasser K Altorki, Zachary H Walsh, Johannes C Melms, Jeffery L Port, Benjamin E Lee, Abu Nasar, Cathy Spinelli, Lindsay Caprio, Meri Rogava, Patricia Ho, Paul J Christos, Ashish Saxena, Olivier Elemento, Bhavneet Bhinder, Casey Ager, Amit Dipak Amin, Nicholas J Sanfilippo, Vivek Mittal, Alain C Borczuk, Sylvia C Formenti, Benjamin Izar, Timothy E McGraw
Author Correction: Neoadjuvant durvalumab plus radiation versus durvalumab alone in stages I-III non-small cell lung cancer: survival outcomes and molecular correlates of a randomized phase II trial. Nature communications 15 (1) (2024)
Zachary H Walsh, Parin Shah, Neeharika Kothapalli, Shivem B Shah, Gergő Nikolényi, D Zack Brodtman, Giuseppe Leuzzi, Meri Rogava, Michael Mu, Patricia Ho, Sinan Abuzaid, Neil Vasan, Mohammed AlQuraishi, Joshua D Milner, Alberto Ciccia, Johannes C Melms, Benjamin Izar
Mapping variant effects on anti-tumor hallmarks of primary human T cells with base-editing screens. Nature biotechnology (2024)
Nasser K Altorki, Zachary H Walsh, Johannes C Melms, Jeffery L Port, Benjamin E Lee, Abu Nasar, Cathy Spinelli, Lindsay Caprio, Meri Rogava, Patricia Ho, Paul J Christos, Ashish Saxena, Olivier Elemento, Bhavneet Bhinder, Casey Ager, Amit Dipak Amin, Nicholas J Sanfilippo, Vivek Mittal, Alain C Borczuk, Sylvia C Formenti, Benjamin Izar, Timothy E McGraw
Author Correction: Neoadjuvant durvalumab plus radiation versus durvalumab alone in stages I-III non-small cell lung cancer: survival outcomes and molecular correlates of a randomized phase II trial. Nature communications 15 (1) (2024)
Nasser K Altorki, Zachary H Walsh, Johannes C Melms, Jeffery L Port, Benjamin E Lee, Abu Nasar, Cathy Spinelli, Lindsay Caprio, Meri Rogava, Patricia Ho, Paul J Christos, Ashish Saxena, Olivier Elemento, Bhavneet Bhinder, Casey Ager, Amit Dipak Amin, Nicholas J Sanfilippo, Vivek Mittal, Alain C Borczuk, Sylvia C Formenti, Benjamin Izar, Timothy E McGraw
Neoadjuvant durvalumab plus radiation versus durvalumab alone in stages I-III non-small cell lung cancer: survival outcomes and molecular correlates of a randomized phase II trial. Nature communications 14 (1) (2023)
Nasser K Altorki, Zachary H Walsh, Johannes C Melms, Jeffery L Port, Benjamin E Lee, Abu Nasar, Cathy Spinelli, Lindsay Caprio, Meri Rogava, Patricia Ho, Paul J Christos, Ashish Saxena, Olivier Elemento, Bhavneet Bhinder, Casey Ager, Amit Dipak Amin, Nicholas J Sanfilippo, Vivek Mittal, Alain C Borczuk, Sylvia C Formenti, Benjamin Izar, Timothy E McGraw
Neoadjuvant durvalumab plus radiation versus durvalumab alone in stages I-III non-small cell lung cancer: survival outcomes and molecular correlates of a randomized phase II trial. Nature communications 14 (1) (2023)
Nasser K Altorki, Zachary H Walsh, Johannes C Melms, Jeffery L Port, Benjamin E Lee, Abu Nasar, Cathy Spinelli, Lindsay Caprio, Meri Rogava, Patricia Ho, Paul J Christos, Ashish Saxena, Olivier Elemento, Bhavneet Bhinder, Casey Ager, Amit Dipak Amin, Nicholas J Sanfilippo, Vivek Mittal, Alain C Borczuk, Sylvia C Formenti, Benjamin Izar, Timothy E McGraw
Neoadjuvant durvalumab plus radiation versus durvalumab alone in stages I-III non-small cell lung cancer: survival outcomes and molecular correlates of a randomized phase II trial. Nature communications 14 (1) (2023)
Nasser K Altorki, Zachary H Walsh, Johannes C Melms, Jeffery L Port, Benjamin E Lee, Abu Nasar, Cathy Spinelli, Lindsay Caprio, Meri Rogava, Patricia Ho, Paul J Christos, Ashish Saxena, Olivier Elemento, Bhavneet Bhinder, Casey Ager, Amit Dipak Amin, Nicholas J Sanfilippo, Vivek Mittal, Alain C Borczuk, Sylvia C Formenti, Benjamin Izar, Timothy E McGraw
Neoadjuvant durvalumab plus radiation versus durvalumab alone in stages I-III non-small cell lung cancer: survival outcomes and molecular correlates of a randomized phase II trial. Nature communications 14 (1) (2023)
Nasser K Altorki, Zachary H Walsh, Johannes C Melms, Jeffery L Port, Benjamin E Lee, Abu Nasar, Cathy Spinelli, Lindsay Caprio, Meri Rogava, Patricia Ho, Paul J Christos, Ashish Saxena, Olivier Elemento, Bhavneet Bhinder, Casey Ager, Amit Dipak Amin, Nicholas J Sanfilippo, Vivek Mittal, Alain C Borczuk, Sylvia C Formenti, Benjamin Izar, Timothy E McGraw
Neoadjuvant durvalumab plus radiation versus durvalumab alone in stages I-III non-small cell lung cancer: survival outcomes and molecular correlates of a randomized phase II trial. Nature communications 14 (1) (2023)
Nasser K Altorki, Zachary H Walsh, Johannes C Melms, Jeffery L Port, Benjamin E Lee, Abu Nasar, Cathy Spinelli, Lindsay Caprio, Meri Rogava, Patricia Ho, Paul J Christos, Ashish Saxena, Olivier Elemento, Bhavneet Bhinder, Casey Ager, Amit Dipak Amin, Nicholas J Sanfilippo, Vivek Mittal, Alain C Borczuk, Sylvia C Formenti, Benjamin Izar, Timothy E McGraw
Neoadjuvant durvalumab plus radiation versus durvalumab alone in stages I-III non-small cell lung cancer: survival outcomes and molecular correlates of a randomized phase II trial. Nature communications 14 (1) (2023)
Nasser K Altorki, Zachary H Walsh, Johannes C Melms, Jeffery L Port, Benjamin E Lee, Abu Nasar, Cathy Spinelli, Lindsay Caprio, Meri Rogava, Patricia Ho, Paul J Christos, Ashish Saxena, Olivier Elemento, Bhavneet Bhinder, Casey Ager, Amit Dipak Amin, Nicholas J Sanfilippo, Vivek Mittal, Alain C Borczuk, Sylvia C Formenti, Benjamin Izar, Timothy E McGraw
Neoadjuvant durvalumab plus radiation versus durvalumab alone in stages I-III non-small cell lung cancer: survival outcomes and molecular correlates of a randomized phase II trial. Nature communications 14 (1) (2023)
Nasser K Altorki, Zachary H Walsh, Johannes C Melms, Jeffery L Port, Benjamin E Lee, Abu Nasar, Cathy Spinelli, Lindsay Caprio, Meri Rogava, Patricia Ho, Paul J Christos, Ashish Saxena, Olivier Elemento, Bhavneet Bhinder, Casey Ager, Amit Dipak Amin, Nicholas J Sanfilippo, Vivek Mittal, Alain C Borczuk, Sylvia C Formenti, Benjamin Izar, Timothy E McGraw
Neoadjuvant durvalumab plus radiation versus durvalumab alone in stages I-III non-small cell lung cancer: survival outcomes and molecular correlates of a randomized phase II trial. Nature communications 14 (1) (2023)
Nasser K Altorki, Zachary H Walsh, Johannes C Melms, Jeffery L Port, Benjamin E Lee, Abu Nasar, Cathy Spinelli, Lindsay Caprio, Meri Rogava, Patricia Ho, Paul J Christos, Ashish Saxena, Olivier Elemento, Bhavneet Bhinder, Casey Ager, Amit Dipak Amin, Nicholas J Sanfilippo, Vivek Mittal, Alain C Borczuk, Sylvia C Formenti, Benjamin Izar, Timothy E McGraw
Neoadjuvant durvalumab plus radiation versus durvalumab alone in stages I-III non-small cell lung cancer: survival outcomes and molecular correlates of a randomized phase II trial. Nature communications 14 (1) (2023)
Nasser K Altorki, Zachary H Walsh, Johannes C Melms, Jeffery L Port, Benjamin E Lee, Abu Nasar, Cathy Spinelli, Lindsay Caprio, Meri Rogava, Patricia Ho, Paul J Christos, Ashish Saxena, Olivier Elemento, Bhavneet Bhinder, Casey Ager, Amit Dipak Amin, Nicholas J Sanfilippo, Vivek Mittal, Alain C Borczuk, Sylvia C Formenti, Benjamin Izar, Timothy E McGraw
Neoadjuvant durvalumab plus radiation versus durvalumab alone in stages I-III non-small cell lung cancer: survival outcomes and molecular correlates of a randomized phase II trial. Nature communications 14 (1) (2023)
Frank P B Dubios, Ofer Shapira, Noah F Greenwald, Travis Zack, Jeremiah Wala, Jessica W Tsai, Alexander Crane, Audrey Baguette, Djihad Hadjadj, Ashot S Harutyunyan, Kiran H Kumar, Mirjam Blattner-Johnson, Jayne Vogelzang, Cecilia Sousa, Kyung Shin Kang, Claire Sinai, Dayle K Wang, Prasidda Khadka, Kathleen Lewis, Lan Nguyen, Hayley Malkin, Patricia Ho, Ryan O'Rourke, Shu Zhang, Rose Gold, Davy Deng, Jonathan Serrano, Matija Snuderl, Chris Jones, Karen D Wright, Susan N Chi, Jacques Grill, Claudia L Kleinman, Liliana Christova Goumnerova, Nada Jabado, David T W Jones, Mark W Kieran, Keith L Ligon, Rameen Beroukhim, Pratiti Bandopadhayay
Structural variants shape driver combinations and outcomes in pediatric high-grade glioma. Nature cancer 3 (8) (2022)
Johannes C Melms, Jana Biermann, Huachao Huang, Yiping Wang, Bindu Nair, Somnath Tagore, Igor Katsyv, André F Rendeiro, Amit Dipak Amin, Denis Schapiro, Chris J Frangieh, Adrienne M Luoma, Aveline Filliol, Yinshan Fang, Hiranmayi Ravichandran, Mariano G Clausi, George A Alba, Meri Rogava, Sean W Chen, Patricia Ho, Daniel T Montoro, Adam E Kornberg, Arnold S Han, Mathieu F Bakhoum, Niroshana Anandasabapathy, Mayte Suárez-Fariñas, Samuel F Bakhoum, Yaron Bram, Alain Borczuk, Xinzheng V Guo, Jay H Lefkowitch, Charles Marboe, Stephen M Lagana, Armando Del Portillo, Emily J Tsai, Emmanuel Zorn, Glen S Markowitz, Robert F Schwabe, Robert E Schwartz, Olivier Elemento, Anjali Saqi, Hanina Hibshoosh, Dominique Bailey, Benjamin Izar
A molecular single-cell lung atlas of lethal COVID-19. Nature 595 (7865) (2021)
Chris J Frangieh, Johannes C Melms, Pratiksha I Thakore, Kathryn R Geiger-Schuller, Patricia Ho, Adrienne M Luoma, Brian Cleary, Livnat Jerby, Shruti Malu, Michael S Cuoco, Maryann Zhao, Casey R Ager, Meri Rogava, Lila Hovey, Asaf Rotem, Chantale Bernatchez, Kai W Wucherpfennig, Bruce E Johnson, Orit Rozenblatt-Rosen, Dirk Schadendorf, Aviv Regev, Benjamin Izar
Multimodal pooled Perturb-CITE-seq screens in patient models define mechanisms of cancer immune evasion. Nature genetics 53 (3) (2021)
Mehdi Touat, Yvonne Y Li, Adam N Boynton, Liam F Spurr, J Bryan Iorgulescu, Craig L Bohrson, Isidro Cortes-Ciriano, Cristina Birzu, Jack E Geduldig, Kristine Pelton, Mary Jane Lim-Fat, Sangita Pal, Ruben Ferrer-Luna, Shakti H Ramkissoon, Frank Dubois, Charlotte Bellamy, Naomi Currimjee, Juliana Bonardi, Kenin Qian, Patricia Ho, Seth Malinowski, Leon Taquet, Robert E Jones, Aniket Shetty, Kin-Hoe Chow, Radwa Sharaf, Dean Pavlick, Lee A Albacker, Nadia Younan, Capucine Baldini, Maïté Verreault, Marine Giry, Erell Guillerm, Samy Ammari, Frédéric Beuvon, Karima Mokhtari, Agusti Alentorn, Caroline Dehais, Caroline Houillier, Florence Laigle-Donadey, Dimitri Psimaras, Eudocia Q Lee, Lakshmi Nayak, J Ricardo McFaline-Figueroa, Alexandre Carpentier, Philippe Cornu, Laurent Capelle, Bertrand Mathon, Jill S Barnholtz-Sloan, Arnab Chakravarti, Wenya Linda Bi, E Antonio Chiocca, Katie Pricola Fehnel, Sanda Alexandrescu, Susan N Chi, Daphne Haas-Kogan, Tracy T Batchelor, Garrett M Frampton, Brian M Alexander, Raymond Y Huang, Azra H Ligon, Florence Coulet, Jean-Yves Delattre, Khê Hoang-Xuan, David M Meredith, Sandro Santagata, Alex Duval, Marc Sanson, Andrew D Cherniak, Patrick Y Wen, David A Reardon, Aurélien Marabelle, Peter J Park, Ahmed Idbaih, Rameen Beroukhim, Pratiti Bandopadhayay, Franck Bielle, Keith L Ligon
Mechanisms and therapeutic implications of hypermutation in gliomas. Nature 580 (7804) (2020)